Related News
Sinovac gets world's 1st production license for A/H1N1 flu vaccine
CHINA approved today the A/H1N1flu vaccine produced by domestic pharmaceutical company Sinovac, making it the first to get a production license in the global race.
The State Food and Drug Administration (SFDA) issued the license for Sinovac' s vaccine called Panflu.1 today, after it passed SFDA' s experts evaluation on Aug. 31.
Panflu.1 could safely be given to people aged from 3 to 60 years old in a single shot, 15 microgram dose, according to the evaluation report.
Sinovac had the capacity to produce 5 million doses of vaccine before Oct.1, and 20 million to 30 million doses per year, said president Yin Weidong.
Another A/H1N1 flu vaccine, produced by Chinese pharmaceutical company Hualan Biological Engineering Inc., is also hopeful to be given the country's second approval this week.
The State Food and Drug Administration (SFDA) issued the license for Sinovac' s vaccine called Panflu.1 today, after it passed SFDA' s experts evaluation on Aug. 31.
Panflu.1 could safely be given to people aged from 3 to 60 years old in a single shot, 15 microgram dose, according to the evaluation report.
Sinovac had the capacity to produce 5 million doses of vaccine before Oct.1, and 20 million to 30 million doses per year, said president Yin Weidong.
Another A/H1N1 flu vaccine, produced by Chinese pharmaceutical company Hualan Biological Engineering Inc., is also hopeful to be given the country's second approval this week.
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.